Ampersand Capital Partners Acquires CurTec
July 21, 2025
Ampersand Capital Partners has acquired CurTec Group B.V., a Netherlands-based manufacturer of high-performance plastic packaging for pharmaceutical and specialty chemical applications, from Bencis Capital Partners in partnership with CurTec management. The deal positions Ampersand to scale CurTec's U.S. footprint, accelerate product innovation, and expand capacity and commercial capabilities to serve pharma and specialty chemicals customers globally.
- Buyers
- Ampersand Capital Partners
- Targets
- CurTec Group B.V.
- Sellers
- Bencis Capital Partners, CurTec management
- Industry
- Packaging
- Location
- North Brabant, Netherlands
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Ampersand Capital Partners Acquires Specac Ltd.
March 13, 2024
Manufacturing
Ampersand Capital Partners, a Boston-based private equity firm focused on healthcare and life sciences, has acquired Specac Ltd., a UK-based designer and manufacturer of FTIR spectroscopy accessories and sample preparation solutions. The acquisition will support Specac's growth trajectory and leverage Ampersand's experience in life-sciences-oriented lab products and OEM channels.
-
Ampersand Capital Partners Acquires Purna Pharmaceuticals
February 12, 2026
Pharmaceuticals
Ampersand Capital Partners acquired Purna Pharmaceuticals, a Belgian contract development and manufacturing provider of liquid and semi-solid pharmaceutical dosage forms. The investment positions Purna to collaborate with Ampersand portfolio company MedPharm to create a trans‑Atlantic topical and transdermal development and manufacturing offering; Creafund, Purna's prior investor, supported the company for more than a decade and was referenced in the transaction announcement.
-
Ampersand Capital Partners Invests in Syft Technologies
April 18, 2022
Manufacturing
Ampersand Capital Partners made a minority growth equity investment in Syft Technologies Limited to accelerate the company's progress in the semiconductor market and develop scalable opportunities in life sciences. The investment will also bring Ampersand partner David Patteson to Syft’s board to support commercial growth and scale-up.
-
ProAmpac Acquires Specialty Packaging, Inc.
May 23, 2022
Packaging
ProAmpac, a Cincinnati-based flexible packaging manufacturer owned by Pritzker Private Capital, has acquired Specialty Packaging, Inc., a family-owned paper, film and foil packaging manufacturer based in Fort Worth, Texas. The acquisition expands ProAmpac's paper bag converting capacity, broadens its recyclable foodservice packaging portfolio and extends its footprint into the southwestern United States.
-
Ampersand Capital Partners Invests in Magritek
March 18, 2021
Medical Devices
Ampersand Capital Partners made a minority growth investment in Magritek, a New Zealand-based maker of benchtop and portable NMR instruments. The investment will support Magritek's product expansion and market growth (including flow chemistry and bioprocess monitoring) while leveraging Ampersand's healthcare-focused private equity expertise.
-
Ampersand Capital Partners Majority Recapitalizes Julius Clinical Research
November 28, 2023
Healthcare Services
Ampersand Capital Partners has completed a majority recapitalization of Julius Clinical Research, a Zeist-based clinical CRO, to support geographic expansion and deepen the company's scientific and therapeutic expertise. The investment will help Julius grow its CRO services in CNS, renal, cardiometabolic and infectious disease areas and expand its footprint in Europe and North America.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.